Skip to main content

GW Pharma Produces Prescription Cannabinoid Medicine

Movies Preview

movies
GW Pharma Produces Prescription Cannabinoid Medicine

by CNBC



Justin Gover, managing director of GW Pharmaceuticals, told CNBC, "we have developed a product called Sativex, it is derived from two standardised extracts of specific plant types of Cannabis." http://video.cnbc.com/gallery/?video=3000060662

Mr. Justin Gover, BSc, MBA has been Managing Director of GW Pharmaceuticals PLC at GW Research Ltd since January 1999 and serves as its Chief Executive Officer. Mr. Gover is responsible for managing GW Pharmaceuticals's operations, equity financing and business development activities. Mr. Gover has 13 years' of experience in the biotech industry. Previously, he served as the Head of Corporate Affairs at Ethical Holdings plc, where he was responsible for strategic corporate activities, including mergers and acquisitions, equity financing and investor relations. He serves as an Executive Director at GW Pharmaceuticals PLC. He served as a Member of the Advisory Committee of Dawn Capital. Mr. Gover holds an MBA degree from the INSEAD business school in France. http://investing.businessweek.com/research/stocks/people/person.asp?personId=8421094&ticker=GWP:LN


Producer CNBC
Language English

comment
Reviews

There are no reviews yet. Be the first one to write a review.
SIMILAR ITEMS (based on metadata)
eye
Title
Date Archived
Creator
Community Video
movies
eye 365
favorite 0
comment 0
Community Texts
texts
eye 1,743
favorite 1
comment 0
Community Video
by GW Pharmaceuticals
movies
eye 100
favorite 1
comment 0
Community Video
by Patients Out of Time
movies
eye 169,263
favorite 5
comment 0
Community Video
movies
eye 20
favorite 1
comment 0
Community Texts
texts
eye 36
favorite 1
comment 0
Community Texts
by Rudolf Brenneisen
texts
eye 46
favorite 1
comment 0
Community Texts
by IACM
texts
eye 56
favorite 1
comment 0
Community Texts
texts
eye 62
favorite 1
comment 0